X
Scotland says no to Yescarta, but backs Kymriah
https://pharmaphorum.com/news/scotland-says-no-to-yescarta-but-backs-kymriah/
Kymriah
Oxford BioMedica could get $100m following CAR-T approval
UK biotech will supply key component of Novartis’ newly approved cancer cell therapy
UK pharma stays ambitious despite Brexit, looks to new era in cell therapy
The UK can be a leader in cell and gene therapy, but Brexit is a once-in-a-generation challenge
